BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29777540)

  • 1. Pemphigus foliaceus and acquired haemophilia: a rare but important association with life-threatening consequences.
    Wernham AG; Peng C; Bailiff B; Ilchyshyn A
    Clin Exp Dermatol; 2018 Oct; 43(7):825-828. PubMed ID: 29777540
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
    Kim MR; Kim HC; Kim SC
    Dermatology; 2011; 223(2):182-8. PubMed ID: 22025028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infective endocarditis due to Enterococcus faecalis manifesting as pemphigus foliaceus.
    Ioannou P; Tsagkaraki E; Vamvoukaki R; Kouvidou C; Krasagakis K; Chamilos G; Gikas A
    Hellenic J Cardiol; 2019; 60(3):202-204. PubMed ID: 30092274
    [No Abstract]   [Full Text] [Related]  

  • 4. Acquired haemophilia treated successfully with rituximab in a patient with pemphigus vulgaris.
    Chiba T; Tsuji G; Mitoma H; Takahara M; Moroi Y; Miyamoto T; Furue M
    Haemophilia; 2013 Mar; 19(2):e98-9. PubMed ID: 23419110
    [No Abstract]   [Full Text] [Related]  

  • 5. Refractory pemphigus foliaceous treated with rituximab.
    Awdeh F; Gilhooley E; O Grady C; Connolly M
    BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31147410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acquired factor VIIIc inhibitors. Two cases and a review of the literature].
    Bayani N; Lelong F
    Ann Med Interne (Paris); 2001 Apr; 152(3):201-8. PubMed ID: 11431582
    [No Abstract]   [Full Text] [Related]  

  • 7. [Unexpected positive outcome following rituximab treatment in a patient with pemphigus vegetans resistant to conventional therapies: a case report].
    Barbach Y; Baybay H; Mrabat S; Chaouche M; Elloudi S; Mernissi FZ
    Pan Afr Med J; 2019; 32():101. PubMed ID: 31223391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose rituximab and concurrent adjuvant therapy for pemphigus: Protocol and single-centre long-term review of nine patients.
    Robinson AJ; Vu M; Unglik GA; Varigos GA; Scardamaglia L
    Australas J Dermatol; 2018 Feb; 59(1):e47-e52. PubMed ID: 28211049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexistence case of bullous pemphigoid and pemphigus foliaceus.
    Tsujiwaki M; Abe R; Nomura Y; Nishimura M; Hoshina D; Shinkuma S; Natsuga K; Ujiie H; Arita K; Shimizu H
    Eur J Dermatol; 2013; 23(4):552-3. PubMed ID: 24001742
    [No Abstract]   [Full Text] [Related]  

  • 10. Childhood pemphigus vulgaris successfully treated with rituximab.
    Kanwar AJ; Sawatkar GU; Vinay K; Hashimoto T
    Indian J Dermatol Venereol Leprol; 2012; 78(5):632-4. PubMed ID: 22960821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate in the remission induction of a patient with acquired haemophilia A.
    Lee YS; Ng HJ
    Haemophilia; 2010 Jan; 16(1):180-2. PubMed ID: 19780847
    [No Abstract]   [Full Text] [Related]  

  • 12. [Association of seborrheic pemphigus and Hashimoto autoimmune thyroiditis. Apropos of a further case].
    Goucha S; Mokhtar I; Fazaa B; Yaalaoui S; Zéglaoui F; Kamoun MR
    Rev Med Interne; 2002 Mar; 23(3):336-7. PubMed ID: 11928385
    [No Abstract]   [Full Text] [Related]  

  • 13. Fatal occurrence of acquired haemophilia A in a patient with pemphigus vulgaris.
    Maglie R; Quintarelli L; Lastrucci I; Senatore S; Montefusco F; Pimpinelli N; Antiga E
    Clin Exp Dermatol; 2019 Oct; 44(7):e247-e248. PubMed ID: 31183894
    [No Abstract]   [Full Text] [Related]  

  • 14. [A man in his 80s with muscle stiffness and skin bleeding].
    Tvedt TH; Holme PA; Bruserud Ø
    Tidsskr Nor Laegeforen; 2014 May; 134(10):1058-61. PubMed ID: 24865732
    [No Abstract]   [Full Text] [Related]  

  • 15. A low-dose rituximab regimen for first-line treatment of acquired haemophilia A.
    Hunt S; Robertson J; Conn J; Casey J; Royle J; Collins J; Hourigan M; Richmond J; Yang Wang T; Mills A; Mason J
    Eur J Haematol; 2022 Jan; 108(1):28-33. PubMed ID: 34528303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-desmoglein-1 levels as predictor of prednisolone tapering in pemphigus vulgaris patients treated with rituximab.
    Balighi K; Sakhi RS; Daneshpazhooh M; Mahmoudi H; Teimourpour A; Tavakolpour S
    Dermatol Ther; 2018 Nov; 31(6):e12671. PubMed ID: 30246907
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of severe pemphigus vulgaris of the scalp with adjuvant rituximab and immunoadsorption.
    Kamphausen I; Schulze F; Schmidt E; Zillikens D; Kunz M
    Eur J Dermatol; 2012; 22(6):786-7. PubMed ID: 23114083
    [No Abstract]   [Full Text] [Related]  

  • 18. Etiology of pyrexia in pemphigus patients: a dermatologist's enigma.
    Qadim HH; Hasani A; Zinus BM; Orang NJ; Hasani A
    Indian J Dermatol Venereol Leprol; 2012; 78(6):774. PubMed ID: 23075657
    [No Abstract]   [Full Text] [Related]  

  • 19. Nail manifestations in pemphigus vulgaris.
    Cahali JB; Kakuda EY; Santi CG; Maruta CW
    Rev Hosp Clin Fac Med Sao Paulo; 2002; 57(5):229-34. PubMed ID: 12436180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pemphigus foliaceus in 91 dogs.
    Mueller RS; Krebs I; Power HT; Fieseler KV
    J Am Anim Hosp Assoc; 2006; 42(3):189-96. PubMed ID: 16611930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.